Betrixaban for preventing venous thromboembolism in people hospitalised for acute medical conditions [ID913]
Discontinued
Reference number: GID-TA10154
On 26 July 2018, the Committee for Medicinal Products for Human Use (CHMP) re-examined the opinion and confirmed the refusal of the marketing authorisation. Therefore this topic will remain indefinitely suspended on the NICE work programme.